QSS
AUPH icon

Quantitative Systematic Strategies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quantitative Systematic Strategies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,604
Closed -$348K – 610
2020
Q3 		$348K Buy
23,604
+405
+2% +$5.87K 0.06% 402
2020
Q2 		$377K Buy
23,199
+11,977
+107% +$192K 0.07% 373
2020
Q1 		$163K Sell
11,222
-7,042
-39% -$124K 0.13% 214
2019
Q4 		$370K Buy
+18,264
New +$168K 0.05% 401

Other funds holding AUPH

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Quantitative Systematic Strategies's AUPH Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2020, closing a stake of 23,604 shares — an estimated $348K sold.

Quantitative Systematic Strategies first reported a position in AUPH in Q4 2019 and held it in 4 quarters. The position peaked at $377K in Q2 2020. 145 funds tracked by Wall St. Rank hold AUPH as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Aurinia Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 23,604 Aurinia Pharmaceuticals shares in Q4 2020, an estimated $348K.
  • Quantitative Systematic Strategies first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Aurinia Pharmaceuticals position peaked at $377K in Q2 2020.
  • 145 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.